TLR5 and neoplasm: In a mice model, the combined administration of Vibrio vulnificus Flagellin B and Human papillomavirus (HPV) E6/E7-derived peptides has shown an effective anti-tumor response by T-cells activation, which seemed to be independent of the TLR5 expression on the tumor cell surface [16,17].